Angiotensin receptor‐neprilysin inhibitor in symptomatic patients with Duchenne dilated cardiomyopathy: A primetime
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13963
Abstract: Duchenne muscular dystrophy (DMD) is an X‐linked recessive neuromuscular disorder, characterized by significant long‐term cardiac involvement. Dilated cardiomyopathy (DCM) is the main cause of death in DMD, and angiotensin‐converting enzyme inhibitors (ACEi) and beta‐blockers (BB)… read more here.
Keywords: angiotensin; neprilysin inhibitor; receptor neprilysin; angiotensin receptor ... See more keywords
Effects of angiotensin receptor‐neprilysin inhibitor on insulin resistance in patients with heart failure
Sign Up to like & getrecommendations! Published in 2023 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14352
Abstract: Although the haemodynamic effects of angiotensin receptor‐neprilysin inhibitor (ARNI) on patients with heart failure have been demonstrated, the effect on glucose metabolism has not been fully elucidated. We retrospectively investigated the effect of ARNI on… read more here.
Keywords: heart failure; effects angiotensin; receptor neprilysin; heart ... See more keywords
Angiotensin receptor-neprilysin inhibitor (ARNi): Clinical studies on a new class of drugs.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2016.06.083
Abstract: Sacubritil∗valsartan (Entresto, Novartis, still commonly referred to as LCZ696) is a combination drug described as a new class of dual-acting angiotensin receptor-neprilysin inhibitor (ARNi). This combination drug has been successfully studied in patients with heart… read more here.
Keywords: new class; angiotensin receptor; receptor neprilysin; neprilysin inhibitor ... See more keywords
Post-Discharge Initiation of Angiotensin Receptor-Neprilysin Inhibitor in an Inotrope-Dependent Patient in the Outpatient Setting: A Case Report
Sign Up to like & getrecommendations! Published in 2020 at "Hospital Pharmacy"
DOI: 10.1177/0018578720946756
Abstract: Purpose: Angiotensin receptor-neprilysin inhibitor (ARNI) therapy has been reported to be initiated in patients on vasoactive medications during acute decompensated heart failure. However, there is... read more here.
Keywords: angiotensin receptor; receptor neprilysin; neprilysin inhibitor;
The Application of Angiotensin Receptor Neprilysin Inhibitor in Cardiovascular Diseases: A Bibliometric Review From 2000 to 2022
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.899235
Abstract: Cardiovascular disease (CVD) has become a huge challenge for the global public health system due to its high morbidity, mortality and severe economic burden. In recent years, angiotensin receptor neprilysin inhibitor (ARNI), a new class… read more here.
Keywords: receptor neprilysin; medicine; angiotensin receptor; neprilysin inhibitor ... See more keywords